abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
SG&A Expense Growth
342.34%
Quarterly · Period ending:
HQL SG&A Expense Growth
Latest reported342.34%period ending
Latest reported342.34%period ending
HQL Quarterly SG&A Growth (QoQ) (0.00% → 342.34%)
Latest values, visible window
High-resolution chart · PNG
HQL sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 342.3366% | |
| -72.8483% | |
| -13.9743% | |
| 17.0357% | |
| 238.2188% | |
| -168.532% | |
| 98.8975% | |
| 92,304.2219% | |
| -5.2399% | |
| 5.3173% | |
| 9.3195% | |
| 8.2844% | |
| -99.9498% | |
| -2.1307% | |
| -4.5091% | |
| 1.3634% | |
| 92,802.436% | |
| 16.2773% | |
| 3.7088% | |
| -9.7996% | |
| -13.4032% | |
| 10.5626% | |
| 19.5066% | |
| 7.2245% | |
| 16.7611% | |
| 117.0576% | |
| -99.9522% | |
| 17.3448% | |
| 174.2922% | |
| 0% | |
| 82.5397% | |
| 0% | |
| 6.7797% | |
| 0% | |
| -13.2353% | |
| 0% | |
| -5.5556% | |
| 0% | |
| 30.9091% | |
| 0% | |
| 7.8431% | |
| 0% | |
| -3.7736% | |
| 0% | |
| 17.7778% | |
| 0% | |
| -4.2553% | |
| 0% | |
| 38.2353% | |
| 0% | |
| 0% | |
| 0% | |
| 21.0526% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |